
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
GTG | Sydney | AUD | Delayed | |
GENE | NASDAQ | USD | Real-time | |
GTG | Frankfurt | EUR | Delayed |
Genetic Technologies Limited (GTG) is an Australia-based diversified molecular diagnostics company. The Company is focused on the development and commercialization of genetic risk assessment technology. The Company is engaged in providing genomics-based tests in health, wellness and serious disease through its GeneType and EasyDNA brands. GTG is focused on developing an integrated predictive genetic testing and assessment tools enabling medical practitioners and their patients to proactively manage health. The Company’s geneType test is for breast cancer, colorectal cancer, ovarian cancer, prostate cancer, coronary artery disease and type two diabetes in a single test. The GeneType offers integrated risk testing for a range of serious conditions. GTG offers cancer predictive testing and assessment tools for physicians. Its Polygenic Risk Scores (PRS) platform offers integrated clinical and genetic risk delivering actionable outcomes from physicians and individuals.
Name | Age | Since | Title |
---|---|---|---|
Peter Irwin Rubinstein | 54 | 2018 | Independent Non-Executive Chairman |
Lindsay Peter Wakefield | 63 | 2014 | Independent Non-Executive Director |
Nicholas Jon Burrows | 61 | 2019 | Independent Non-Executive Director |
Ora K. Gordon | - | 2021 | Member of Scientific & Medical Advisory Board |
Finlay Macrae | - | 2021 | Member of Scientific & Medical Advisory Board |
Jon Emery | - | 2021 | Member of Scientific & Medical Advisory Board |
Jerzy Muchnicki | 65 | 2018 | Non-Independent Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review